HCPLive Network

FDA Approval Delayed for Anti-clotting Agent Brilinta

FDA delays approval for anti-clotting drug Brilinta (ticagrelor)The FDA has again delayed approval for AstraZeneca’s blood thinner Brilinta (ticagrelor), asking the drug maker to supply additional information and analysis of data from the PLATO study.

According to a news release from AstraZeneca, the FDA issued a complete response letter (CRL) for the New Drug Application (NDA) for Brilinta that requested additional analyses of the PLATO data but “did not request that additional studies, including clinical studies, be conducted as a prerequisite for approval of the ticagrelor NDA.”

The news release says that although AZ is “evaluating the contents of the CRL and will respond to the agency's request for additional analyses of the PLATO data as soon as possible,” the company “remains confident in the NDA submission for ticagrelor and in its ability to respond to the agency's questions.”

Reports on this news have noted that Brilinta received marketing approval in Europe earlier this month, prompting speculation that the FDA would follow suit. With today’s announcement that has not proven to be the case, however. Speculation as to the nature of the FDA’s request for additional analysis of PLATO data has focused on concerns that “Brilinta doesn't work as well in American patients as it does in does in those overseas.” According to a FOX Business report, a brokerage Shore Capital note to investors said that “While it is difficult to speculate regarding the exact nature of the FDA's requests, there is a high likelihood that it will be regarding the data from the U.S. cohort and the role of high dose aspirin in generating the US. data.”

CardioBrief has a link to a report from a Leerink Swann research analyst that says “Unless FDA’s request for additional analysis is straightforward and can be turned around rapidly, we believe a 12-month delay is a realistic scenario for AZ assuming 6 months to submit the add’l and a subsequent 6 month review. Historical concerns and issues raised by the panel and FDA focused on the aberrant US and North American subset analyses which raised questions about (1) a potential interaction with high-dose aspirin; (2) an effect on statin metabolism; and (3) differences in treatment algorithm’s between the US and other markets that would result in diminished efficacy.”



Further Reading
Because a key antiviral defense mechanism is present in asthmatics, another defect in their immune system must explain their difficulty combating respiratory viruses, according to researchers from Washington University in St. Louis.
Reports indicate the patient presented with Ebola-like symptoms at a local emergency room and told staff he had recently traveled to Africa. If so, why wasn’t CDC protocol followed, and why was the man sent home?
Young and middle-aged heart attack survivors are more likely to have poor health and low quality of life if they have fewer family and friends to support them in their recovery, according to a study published online Sept. 30 in the Journal of the American Heart Association.
Appropriate use criteria have been developed for the initial use of transthoracic echocardiography in outpatient pediatric cardiology. The guidelines were published online Sept. 29 in the Journal of the American College of Cardiology.
For patients in intensive care units, selective decontamination of the digestive tract (SDD) and selective oropharyngeal decontamination correlate with low levels of antibiotic resistance. These findings were published online Oct. 1 in the Journal of the American Medical Association to coincide with the annual meeting of the European Society of Intensive Care Medicine, held from Sept. 27 to Oct. 1 in Barcelona, Spain.
Work, non-work, and individual factors explain a considerable part of psychological distress, depression, and emotional exhaustion, according to a study published online July 24 in Social Psychiatry and Psychiatric Epidemiology.
A patient at Texas Health Presbyterian Hospital has tested positive for the deadly virus.
More Reading